The University of Rochester Medical Center and Rochester Regional Health will recruit 90 healthy people for a trial examining the safety and efficacy of a potential COVID-19 vaccine developed by Pfizer and BioNTech.
@roccitynews
Use a WORKING treatment:
Lung Center of America approves:
Quote: "Perhaps, the reduction of the cytokines storm in the late stages of the Covid19 infection is the most significant application of IV Vit-C."